This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Angela De Martini

Vice President

Angela De Martini is a vice president in CRA’s Life Sciences Practice, specializing in pharmaceuticals, medical devices, and medical technology.

Angela supports clients in the pharmaceutical, biotech and medical device industries globally. She collaborates with client teams on a broad range of strategic topics including commercial, medical affairs, R&D, as well as portfolio and corporate strategy. Prior to CRA’s acquisition of C1 Consulting in 2017, she was a director at C1 Consulting and held senior positions at a-connect and Navigant (formerly Easton Associates).

Related capabilities
Related capabilities

Selected engagements

  • 01
    Evidence generation for a virtual 3D surgical planning software
    A leading MedTech company sought to demonstrate the unique benefits of their virtual 3D surgical planning software in thoracic surgery, as opposed to the...
    View engagement
  • 02
    A unified patient flow model to prioritize opportunities
    CRA consultants team created a patient flow model for a leading rare disease franchise to identify opportunities for improving diagnosis and treatment rates
    View engagement
  • 03
    Showcasing the value and revenue potential of an asset in development
    A Biotech company sought to quantify the revenue potential and develop a forecast model for their asset, which is currently in early clinical development – the...
    View engagement

Latest insights

Credentials

Get In Touch
Angela De Martini
Zurich +41 41 561 40 31 ademartini@crai.com